Cannabis policy implementation in Ontario (2018-2022)

Canada legalised cannabis for non-medical use in October 2018. While the federal government organises the production of cannabis, it has left it up to its 13 provinces and territories to define a distribution and retail model. Ontario, the most populous province and largest cannabis market in Canada, is at the forefront of this process.

Loi et cannabis
View the bibliographic record on the documentation portal

What is Ontario’s cannabis policy framework and, most importantly, how has it been put into practice? How is the cannabis market structured in Ontario? What are the key trends in the retail space? What are the implementation challenges that stakeholders face with regards to public health, the economy, and vulnerable populations?

These are the main questions addressed by this report. More broadly, this report attempts to highlight and understand the adverse and unplanned outcomes of legalization in Ontario. It relies on two data sources: interviews with cannabis policy stakeholders and an institutional literature review.

Publication type
Reports
Publication date
Language
French
English
Author(s)
LÉVESQUE
Gabriel
Edited by
OFDT
Number of pages
54
ISBN
979-10-92728-67-5
Products & addictions
Cannabis
Themes
Supply and markets
Public policy and healthcare provision
Users
Specific population(s)
Adolescents
Adults
Vulnerable groups
Territories
International
Dispositif d'enquête et d'observation
Public policy analysis

See also

The use of psychoactive substances among adolescents in French overseas territories
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Poppers
  • Nitrous oxide
  • Tobacco
Briefing papers
2024
OFDT
15 pages
Drug use in prison - Results of the 2023 ESSPRI survey
  • Alcohol
  • Cannabis
  • Cocaine and crack
  • Heroin and opioids
  • MDMA/ecstasy and amphetamine
  • Tobacco
Tendances
163
2024
OFDT
6 pages
3 minutes on... What is the difference between legalisation and depenalisation?
  • Cannabis
Videos
2024
OFDT

Latest publications Reports

All publications Reports
Drugs at 17: regional analyses of the 2022 ESCAPAD survey
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Cocaine and crack
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Poppers
  • Nitrous oxide
  • Tobacco
  • Users
  • Auvergne-Rhône-Alpes
  • Bourgogne-Franche-Comté
  • Bretagne
  • Centre-Val-de-Loire
  • Hauts-de-France
  • Île-de-France
  • Normandie
  • Nouvelle-Aquitaine
  • Occitanie
  • Provence-Alpes-Côte d'Azur
  • Pays de la Loire

For the past two decades the Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD) conducted by the OFDT has made it possible to quantify the use of psychoactive substance by 17-year-olds at a regional level.

Reports
2024
OFDT
66 pages
Behavioural addictions: definitions, issues and debates
  • Behavioural addiction
  • Gambling
  • Treatment
  • Users
  • France
  • International

Behavioural addictions still make up a scientific and clinical field under construction, characterised by a low consensus level which results in large numbers of concepts, terms, definitions and measuring tools.

Reports
2023
OFDT
73 pages
Quitting smoking: a review of the social science publications
  • e-Cigarette
  • Tobacco
  • Treatment
  • France

This review of the social science publications on trajectories to quit smoking begins with an account of surveys looking at methods used to help smokers quit and professionals involved in helping them. The second part of the report deals with studies analysing the impact of socioeconomic variables on smoking behaviour and/or cessation.

Reports
2023
OFDT
40 pages
Prescribing practices and use of opioid analgesics: a sociological analysis
  • Heroin and opioids
  • Treatment
  • Users
  • France

The study on the use of analgesic opioid medicines (EMOA) by the French Monitoring Centre for Drugs and Drug Addiction (OFDT) examines their prescription in general practice and the experiences of who consider themselves to be having difficulty with them in the treatment of chronic pain unrelated to cancer in France.

Reports
2023
OFDT
104 pages